MA
TFFP

MYDA Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

MYDA Advisors’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,600
Closed -$355K – 278
2021
Q4 		$355K Hold
1,600
– – 0.09% 178
2021
Q3 		$309K Buy
+1,600
New +$340K 0.09% 190

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

MYDA Advisors's TFFP Position: Q1 2022 in Review

MYDA Advisors sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2022, closing a stake of 1,600 shares — an estimated $355K sold.

MYDA Advisors first reported a position in TFFP in Q3 2021 and held it in 2 quarters. The position peaked at $355K in Q4 2021. 43 funds tracked by Wall St. Rank hold TFFP as of Q1 2022.

  • MYDA Advisors reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • MYDA Advisors sold 1,600 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $355K.
  • MYDA Advisors first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • MYDA Advisors's TFF Pharmaceuticals, Inc. Common Stock position peaked at $355K in Q4 2021.
  • 43 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on MYDA Advisors's 13F filing for Q1 2022, filed 13 May 2022.